The amniotic membrane is the deepest layer of fetal membrane extracted from women's placenta and harvested to be utilized as a transplant material for reconstructive surgery for cases such as severe trauma wounds, burnt skin, chronic wounds, and others. The use of an amniotic membrane is preferred due to its anti-scarring property, non-immunogenicity, antimicrobial property, and ability to reduce inflammation.
Global Amniotic Membrane Market Size was US$ 2.5 Billion in 2021
However, the amniotic membrane is expected to exhibit significant market growth during the forecast period, owing to technological innovations to develop cost-effective therapies. The rise in amniotic membrane transplantation, awareness and education about the benefits of amniotic membrane transplantation, and the growth of the geriatric population propel the market growth. Implementation of the 21st-century cures act, emerging economies, and growing demand for stem cell research and regenerative medicine are anticipated to offer substantial growth opportunities for players in the market. Further, rising government initiatives to improve the healthcare infrastructure result in an increase in demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.
Impact of Covid-19 on Amniotic Membrane Market
The impact of COVID-19 remains negative on the amniotic membrane industry. Due to nationwide lockdowns, restricted wound care services, and canceled or delayed elective surgeries. Elective surgeries were being canceled to reserve or redirect the available limited capacities and resources (like patient care professionals and hospital beds) towards COVID-19 patient care. Additionally, various countries enforced lockdowns and curfews to curb the rise in COVID-19 cases. Due to these lockdowns, patients could not visit OPDs, hospitals, or clinics. This temporary privation of non-emergent healthcare services limits the amniotic product's market growth.
Amniotic Membrane Industry is expected to grow at a CAGR of 13.7% from 2021 to 2027
Based on type, Amniotic Membrane includes Cryopreserved amniotic membranes and Dehydrated Amniotic Membranes. Dehydrated amniotic membranes are typically used to treat various surgical reconstruction procedures, wounds,and venous and pressure leg ulcers. Usually, these applications are used as biological bandages to promote healing. PalinGen, AmbioDisk, FloGraft, and AmnioFix are some examples of commercially available dehydrated amniotic membranes. Therefore, the rising usage of dehydrated membranes is anticipated to fuel the segment growth.
By application, the Amniotic Membrane market is classified into Orthopedics, Ophthalmology, Wound Care, and Others. The wound care applications segment commanded the biggest market of the amniotic product. The large share of the wound care segment is attributed to the growing incidence of traumatic ulcers, surgical wounds, burns, and the need for advanced technologies for treatment.
North America is anticipated to hold a Significant Market Share
Geographically, North America holds the market, owing to the well-established healthcare system and increased adoption of amniotic membranes for varied applications. In addition to the significant infrastructure for developmental research, the availability of substantial research funds and growing government initiatives towards amniotic membrane transplantation are anticipated to drive market growth.
Similarly, the European region accounted for a considerable market. The healthcare scheme in the European region is publicly supported, and European countries have adopted universal health care systems, thereby developing the product demand. A growing number of patients sorrowing from chronic illnesses are anticipated to boost the adoption of amniotic membranes among healthcare professionals.
Key Players:
The amniotic membrane industry is moderately competitive and consists of several prominent players like Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings, Wright Medical Group Inc, MiMedx, and Organogenesis Net.
This report titled Amniotic Membrane Market, Global Forecast, by Type (Cryopreserved amniotic membranes Dehydrated Amniotic Membrane), Application (Orthopedics, Ophthalmology, Wound Care, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research & Academic Institutes), Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) Company Analysis (Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings, Wright Medical Group Inc, MiMedx, and Organogenesis Net)" provides complete analysis on Amniotic Membrane Market
Type - Market have been covered 2 Viewpoints
1. Cryopreserved amniotic membranes
2. Dehydrated Amniotic Membranes
Application - Market have been covered 4 Viewpoints
1. Orthopedics
2. Ophthalmology
3. Wound Care
4. Others
End User- Market have been covered 4 Viewpoints
1. Hospitals
2. Ambulatory Surgical Centers
3. Specialty Clinics
4. Research & Academic Institutes
Region - Market have been covered 5 Viewpoints
1. North America
2. Europe
3. Asia-Pacific
4. Latin America
5. Middle East & Africa
All the key players have been covered 3 Viewpoints
- Overviews
- Recent Developments
- Revenues
Company Analysis
1. Stryker Corporation
2. Smith & Nephew plc
3. Integra LifeSciences Holdings
4. Wright Medical Group Inc
5. MiMedx,
6. Organogenesis Net
What is the estimated value of the Global Amniotic Membrane Market?
What is the growth rate of the Global Amniotic Membrane Market?
What is the forecasted size of the Global Amniotic Membrane Market?
Who are the key companies in the Global Amniotic Membrane Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | March 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 2.5 Billion |
| Forecasted Market Value ( USD | $ 5.4 Billion |
| Compound Annual Growth Rate | 13.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
Table of Contents
Companies Mentioned
- Stryker Corporation
- Smith & Nephew plc
- Integra LifeSciences Holdings
- Wright Medical Group Inc
- MiMedx,
- Organogenesis Net
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
